NCT00863252View on ClinicalTrials.gov

Mycophenolate Mofetil for IgA Nephropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

June 30, 2004

Study Completion Date

March 31, 2009

Conditions
IGA Nephropathy
Interventions
DRUG

mycophenolate mofetil

Orally at 0.75 g bd to 1 g bd for 6 months

DRUG

angiotensin blockade

Continuation of angiotensin blockade

Trial Locations (1)

Unknown

Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong

All Listed Sponsors
collaborator

United Christian Hospital

OTHER

collaborator

Queen Mary Hospital, Hong Kong

OTHER

lead

The University of Hong Kong

OTHER

NCT00863252 - Mycophenolate Mofetil for IgA Nephropathy | Biotech Hunter | Biotech Hunter